Novālent is HACCP Certified

December 9, 2020

Novālent reports its facilities are Hazard Analysis Critical Control Point (HACCP) certified.

“Earning the GMP/HACCP certification in our manufacturing plant is a competitive advantage. This is a big deal when it comes to adding another layer of food safety for our food and beverage customers. In today’s world where there is a heightened awareness for food protection, this certification becomes extremely valuable to the entire food chain.” Mike Motta, Chief Commercial Officer at Novālent, explains.

HACCP certification is an internationally recognized list of requirements established by the Food Safety Modernization Act (FSMA) and Global Food Safety Initiatives (GFSI) standards.

Achieving the certification confirms a company employs effective control of food safety throughout its processes. The principles of this certification are often used to update food safety legislation in countries around the world.

Novālent was assisted in this achievement by Darryle Guarino, CEO at GFSC Group, Inc. who says going through this process is indicative of a modern biochemical company’s dedication to safety.

“Spending time on this certification—and it is a significant time and resources investment—is indicative of a company seeking to modernize its approach to food safety requirements.”

Novālent film technology is for use as a residual antimicrobial under EPA and FDA regulations to preserve food contact surfaces and is used by leading firms including PepsiCo, Sabra, and Pilgrims. Novālent antimicrobial creates an invisible film that stays active and anchored through day to day operations. One application lasts up to 90 days and through multiple cleaning cycles. The company also offers a hand sanitizer.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis.
This new collaboration is another example of Blacksmith's creative deal-making with top tier partners that bring expertise to the table which helps de-risk and accelerate scientific discoveries for the development of valuable products.
Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency.
Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights.
Anna Kazanchyan, MD, Founder and CEO of Saghmos Therapeutics. "We are very pleased to announce the Notice of Allowance for our second patent, which will enhance the long-term value of ST-62516. Saghmos continues to build its intellectual property estate."

By using this website you agree to accept Medical Device News Magazine Privacy Policy